Electroencephalography Devices Market By Product Type (Scalp EEG, Intracranial EEG, Standalone Devices, Portable Devices, Wearable EEG Headsets), By Technology (High-Density EEG, Conventional EEG, Dry Electrode EEG, Wet Electrode EEG), By Application (Disease Diagnosis {Neurological disorders, Sleep disorders, Brain injuries}, Research {Neuroscience studies, Cognitive studies}, Therapeutics {Mental health therapies, Neurorehabilitation}, Others), By End-user (Hospitals, Ambulatory Surgical Centers, Research Institute, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles, And Market Forecast, 2025 – 2035

Industry Outlook

The Electroencephalography Devices Market size was USD 1.82 Billion in 2024 and is projected to reach around USD 5.12 Billion by 2035, at a CAGR of around 9.85% between 2025 and 2035. The Electroencephalography Devices Market is the industry that deals with producing and supplying Electroencephalography equipment that can monitor and record the activity of the human brain.

Such factors as the increasing rate of neurological diseases, the development of non-stationary and portable Electroencephalography Devices, and their expansion in various fields, from research to diagnostics and treatment, motivate the growth of this market. Comprises different sections regarding the product type, the application, technology, specific customers, and regions. The driving factors are increased demand for invasive, less brain monitoring procedures, advancements in neurotechnology, and a rise in health care expenditure globally.

Report Scope:

Market Dynamics

The increasing prevalence of neurological disorders boosts EEG Devices demand globally

The Electroencephalography Devices Market is highly dependent on the increasing incidences of neurological conditions, including epilepsy, sleep disorders, and brain injuries. As reported by WHO today, the global prevalence of epilepsy is about 50 million persons, epilepsy is on the list of the most widespread neurological disorders. Conditions such as insomnia and sleep apnoea combined with the rising concern for mental health disorders are putting pressure on the need for accurate diagnostic equipment.

Devices such as EEG machines help in the real-time quantification and monitoring of such brain disorders and are hence relevant for diagnosing and controlling the disorders. There is an ever-increasing incidence of neurological disorders, and with this comes increased utilization of EEG in clinical settings and research activities, which fuels the growth of the market. The fact that EEG Devices are non-invasive, in addition to the possibility of real-time tracking of brain waveforms, aids in early diagnosis and individualized treatment, which is expected to drive the market ahead.

Technological advancements in portable and wearable Devices support the electroencephalography market

The Electroencephalography Devices Market is in a state of growth, mainly fueled by increased technology in portable and wearable EEGs. These modern Devices allow approaching the task of constant, comfortable, and relatively cheap measurement and control of brain activity, and such brain investigations can be performed outside of a hospital or clinical setting. The initial standard EEG machines were formerly only available in clinical centers; however, novel portable units are adding modernity to the utility for people suffering from epilepsy as well as for doctors.

Recent advancements in the fixing of EEG technology in smartphones, smartwatches, and other wearables have enabled people to monitor brain signals from remote regions. This pattern not only enhances the availability of EEG systems but also provides the instantaneous interpretation and individual attentiveness needed for persistent neurological patients. Thus, these improvements are beneficial not only in terms of improving patients’ experience through offering the possibility to provide more preventive care but also in terms of opening expansive opportunities for the further growth of the Electroencephalography Market all over the globe.

High costs associated with advanced EEG Devices hinder market accessibility

It must be noted that the Electroencephalography Devices Market’s growth is limited by comparatively high costs of initial EEG equipment that can discourage smaller clinics and providers, particularly in developing countries. These Devices are, however, attached to specific instruments as well as applications, and the cost of sufficiently putting them in place further amplifies the expenses. This is a challenge that makes it hard for some of the care facilities to incorporate EEG technology, hence restricting its deployment. There is also the cost of maintaining the EEG Devices, as well as training the staff to operate the equipment a factor that makes the technology unaffordable for low-end health facilities. Among these, the accessibility issue could be well tackled with government support, subsidies, etc. Furthermore, several emerging low-cost and portable EEG solutions also mean growth in market reach in the subsequent years.

Expanding the use of EEG Devices for mental health diagnosis and therapeutic applications

The Electroencephalography Devices Market has scope through its expanding uses in; the diagnosis and treatment of mental disorders such as depression, anxiety, and neurofeedback. EEG Devices are being used more and more for non-invasive psychology of the brain in psychiatric treatments that also show prospects for therapeutic usage and personalized treatments leaving beyond just neurological diseases.

Continuing advances in the personalization of mental health treatment have also promoted the use of EEG to track several brain activity patterns. The study of cognitive behavioral therapies especially EEG-guided biofeedback offers new possibilities for individualized approaches to patients. Some of these can help the market extend its outreach to other areas like psychiatric and wellness centers.

Growing adoption of EEG technology in sleep disorder diagnosis and management

Electroencephalography Devices Market prospects are closely associated with an increase in demand for technologies such as computer interfaces (BCI). BCI systems relay communication between the brain and external Devices, of which EEG gadgets are instrumental. As BCI applications are extended to other domains, including robots, games, and even the disabled, the potential of EEG equipment will enhance, meaning the growth of the industry will be realized in other domains apart from the healthcare sector.

Awareness of sleep health has risen with reactive top-notch diagnostics of conditions such as insomnia and sleep apnea. EEG technology is widely used in sleep clinics since the technology enables the monitoring of brain activity during different cycles of sleep. Also, the portable and disposable EEG headsets intended for home use provide the market with more opportunities for expansion, especially in the segment connected with consumer health.

Industry Experts Opinion

“The Electroencephalography market is witnessing good growth due to the high prevalence rate in the cases of neurological disorders. These innovations in this industry are improving diagnostic precision and turning EEG Devices into a must-have equipment in both practice and study.”

•  Dr. Michael Harrington, MD, PhD, Director of Neurological Research, Center for Brain Health, USA

Segment Analysis

Based on the Product Types, the electroencephalography Devices market is segmented into Scalp EEG, Intracranial EEG, Standalone Devices, Portable Devices, and Wearable EEG Headsets. Scalp EEG systems are applied in the diagnosis of diverse neurological disorders, epilepsy, sleep disorders, and traumatic brain disorders. Intracranial EEG, although more invasive, is crucial in conditions like epilepsy that involve monitoring of electrical activity in a certain part of the brain. Portable Devices in particular are becoming popular due to their point-and-shoot usability, which means continuous monitoring is possible outside of clinical avenues and, as such, is relevant for those with chronic neurological disorders. Also, wearing EEG headsets is becoming an important product; people have an opportunity to control their brain activity with the help of light, convenient Devices.

Based on the Technology, the electroencephalography Devices market is divided into High-Density EEG, Conventional EEG, Dry Electrode EEG, and Wet Electrode EEG. High density is a core segment that gives enhanced functions for fine, detailed mapping of brain activities that are critical in both basic as well as clinical applications. Conventional EEG is still significant in that it is the most commonly used technology around the world, cost-effective, and effective in clinical diagnosis. Dry electrode EEG technology is in its early stage and seems to be a significant development since it does not require heavy conductive gels, thus making it a potential candidate for long-term application. Wet electrode EEG is still used in many clinical centers for objective reasons, such as its increased signal-to-noise ratio and accuracy when compared to other methods used for highly accurate diagnosis.

Regional Analysis

North America is the largest and most developed Electroencephalography Devices Market, primarily due to a developed healthcare sector, emphasis on spending on healthcare, and research on the inner hemisphere of the brain. Especially the United States utilizes EEG systems very in-depth within hospitals, clinics, and scientific institutions of the region. The activities of the main market participants and constant innovations in EEG equipment, including portable and wearable versions, also affect the leadership of North America. Furthermore, the increased incidences of neurological diseases, including epilepsy, sleep disorders, and brain injury, coupled with an aging population, mean the market for EEG technology is high.

Asia-Pacific (APAC) is the fastest-growing region in the Electroencephalography Devices Market due to the growth in urbanization, advancement in the healthcare sector, and a gradual rise in healthcare spending in countries like China, India, and Japan. Actual demand for EEG Devices is being fueled by the increasing incidence of neurological disorders and increasing awareness of mental health disorders in the region. The APAC market is also experiencing increasing support from government bodies as well as increased spending on the healthcare sector that subsequently demands the use of state-of-the-art medical Devices such as EEG Devices. The existence of low-cost approaches and the enhanced use of transportable EEG systems also foster this development.

Competitive Landscape

The Electroencephalography Devices Market is quite fragmented, and leading market players are entering into new technologies and the development of enhancement products, thereby addressing various needs of the customers in clinical, research, and home care settings. Market leaders mainly found in the market include Medtronic, Natus Medical, and Philips Healthcare as key market influencers with strong brand recognition and distribution plans.

These companies are gradually directing resources towards enhancing the capabilities of these systems with next-generation portable and wearable EEG systems for real-time brain monitoring of non-invasive solutions. In addition, the increased need for high-density EEG systems and brain-computer interface (BCI) technologies increases the competition between players and enhances the accuracy and effectiveness of Devices.

Electroencephalography Devices Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent development

• In January 2024, This Australia-based biotechnology company with its operation in the U.S. obtained EEG brain monitoring technologies and Devices from Brain Scientific. It included a disposable NeuroCap and a portable NeuroEEG, as well as a group of 16 patents.
• In January 2024, Gate partnered with Beacon on the biomarkers of EEG in the second-phase trial to treat Major Depressive Disorder (MDD). In the trial, participants wore Beacon’s Dreem 3S headband Devices for experimental EEG and sleep assessment. Starting from mid-2024, the Phase II study of Gate was intended to extend knowledge of and possible therapies for MDD.

Report Coverage

By Product Type

• Scalp EEG
• Intracranial EEG
• Standalone Devices
• Portable Devices
• Wearable EEG Headsets

 By Technology

• High-Density EEG
• Conventional EEG
• Dry Electrode EEG
• Wet Electrode EEG

By Application

• Disease Diagnosis
  • Neurological disorders
  • Sleep disorders
  • Brain injuries
• Research
  • Neuroscience studies
  • Cognitive studies
• Therapeutics
  • Mental health therapies
  • Neurorehabilitation
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Research Institute
• Others

By Region

   North America

• U.S.
• Canada

    Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Natus Medical Inc.
• Medtronic Plc
• Philips Healthcare
• BrainScope Company, Inc.
• Brain Products GmbH
• Electrical Geodesics, Inc.
• NeuroWave Systems, Inc.
• Cognionics, Inc.
• Advanced Brain Monitoring, Inc.
• ANT Neuro
• Cadwell Industries, Inc.
• Nihon Kohden Corporation
• Compumedics Limited
• Fresenius SE & Co. KGaA
• General Electric Company (GE Healthcare)
• Neurosoft
• Lifelines Neuro
• Mitsar
• Micromed
• Emotiv

Frequently Asked Questions (FAQs)